BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kaplan SL, Mason EO. Management of Infections Due to Antibiotic-Resistant Streptococcus pneumoniae. Clin Microbiol Rev 1998;11:628-44. [DOI: 10.1128/cmr.11.4.628] [Cited by in Crossref: 159] [Cited by in F6Publishing: 43] [Article Influence: 6.6] [Reference Citation Analysis]
Number Citing Articles
1 Kim GL, Seon SH, Rhee DK. Pneumonia and Streptococcus pneumoniae vaccine. Arch Pharm Res 2017;40:885-93. [PMID: 28735461 DOI: 10.1007/s12272-017-0933-y] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
2 Sahm DF, Thornsberry C, Mayfield DC, Jones ME, Karlowsky JA. In vitro activities of broad-spectrum cephalosporins against nonmeningeal isolates of Streptococcus pneumoniae: MIC interpretation using NCCLS M100-S12 recommendations. J Clin Microbiol 2002;40:669-74. [PMID: 11825993 DOI: 10.1128/JCM.40.2.669-674.2002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
3 Bartlett JG, Dowell SF, Mandell LA, File Jr TM, Musher DM, Fine MJ. Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clin Infect Dis. 2000;31:347-382. [PMID: 10987697 DOI: 10.1086/313954] [Cited by in Crossref: 1035] [Cited by in F6Publishing: 828] [Article Influence: 47.0] [Reference Citation Analysis]
4 Cottagnoud P, Acosta F, Cottagnoud M, Täuber MG. Gemifloxacin is efficacious against penicillin-resistant and quinolone-resistant pneumococci in experimental meningitis. Antimicrob Agents Chemother 2002;46:1607-9. [PMID: 11959614 DOI: 10.1128/AAC.46.5.1607-1609.2002] [Cited by in Crossref: 16] [Article Influence: 0.8] [Reference Citation Analysis]
5 Barroso DE, Godoy D, Castiñeiras TM, Tulenko MM, Rebelo MC, Harrison LH. β-Lactam resistance, serotype distribution, and genotypes of meningitis-causing Streptococcus pneumoniae, Rio de Janeiro, Brazil. Pediatr Infect Dis J 2012;31:30-6. [PMID: 21860337 DOI: 10.1097/INF.0b013e31822f8a92] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
6 Nieto C, Cherny I, Khoo SK, de Lacoba MG, Chan WT, Yeo CC, Gazit E, Espinosa M. The yefM-yoeB toxin-antitoxin systems of Escherichia coli and Streptococcus pneumoniae: functional and structural correlation. J Bacteriol 2007;189:1266-78. [PMID: 17071753 DOI: 10.1128/JB.01130-06] [Cited by in Crossref: 52] [Cited by in F6Publishing: 37] [Article Influence: 3.3] [Reference Citation Analysis]
7 Hsueh PR, Liu YC, Shyr JM, Wu TL, Yan JJ, Wu JJ, Leu HS, Chuang YC, YJ Lau, Luh KT. Multicenter surveillance of antimicrobial resistance of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in Taiwan during the 1998-1999 respiratory season. Antimicrob Agents Chemother 2000;44:1342-5. [PMID: 10770773 DOI: 10.1128/AAC.44.5.1342-1345.2000] [Cited by in Crossref: 36] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
8 Hsueh PR, Luh KT. Antimicrobial resistance in Streptococcus pneumoniae, Taiwan. Emerg Infect Dis 2002;8:1487-91. [PMID: 12498668 DOI: 10.3201/eid0812.020178] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 1.4] [Reference Citation Analysis]
9 Decousser JW, Pina P, Viguier F, Picot F, Courvalin P, Allouch P; ColBVH Study Group. Invasive Streptococcus pneumoniae in France: antimicrobial resistance, serotype, and molecular epidemiology findings from a monthly national study in 2000 to 2002. Antimicrob Agents Chemother 2004;48:3636-9. [PMID: 15328146 DOI: 10.1128/AAC.48.9.3636-3639.2004] [Cited by in Crossref: 29] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
10 Ibrahim YM, Kerr AR, McCluskey J, Mitchell TJ. Role of HtrA in the virulence and competence of Streptococcus pneumoniae. Infect Immun 2004;72:3584-91. [PMID: 15155668 DOI: 10.1128/IAI.72.6.3584-3591.2004] [Cited by in Crossref: 88] [Cited by in F6Publishing: 50] [Article Influence: 4.9] [Reference Citation Analysis]
11 Cottagnoud P, Pfister M, Acosta F, Cottagnoud M, Flatz L, Kühn F, Müller HP, Stucki A. Daptomycin is highly efficacious against penicillin-resistant and penicillin- and quinolone-resistant pneumococci in experimental meningitis. Antimicrob Agents Chemother 2004;48:3928-33. [PMID: 15388454 DOI: 10.1128/AAC.48.10.3928-3933.2004] [Cited by in Crossref: 79] [Cited by in F6Publishing: 18] [Article Influence: 4.4] [Reference Citation Analysis]
12 Scheifele D, Halperin S, Pelletier L, Talbot J, Lovgren M, Vaudry W, Jadavji T, Law B, Macdonald N, Gold R, Wang E, Mills E, Lebel M, Déry P, Morris R. Reduced susceptibility to penicillin among pneumococci causing invasive infection in children - Canada, 1991 to 1998. Can J Infect Dis 2001;12:241-6. [PMID: 18159346 DOI: 10.1155/2001/984958] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
13 Denneman L, Vial-Dupuy A, Gault N, Wolff M, van de Beek D, Mourvillier B. Repeated lumbar puncture in adults with pneumococcal meningitis: an observational study. J Infect 2013;67:350-3. [PMID: 23664854 DOI: 10.1016/j.jinf.2013.05.001] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
14 Cottagnoud P, Acosta F, Cottagnoud M, Pfister M, Täuber MG. Efficacies of BMS 284756 against penicillin-sensitive, penicillin-resistant, and quinolone-resistant pneumococci in experimental meningitis. Antimicrob Agents Chemother 2002;46:184-7. [PMID: 11751131 DOI: 10.1128/AAC.46.1.184-187.2002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
15 Schrag SJ, Beall B, Dowell SF. Limiting the spread of resistant pneumococci: biological and epidemiologic evidence for the effectiveness of alternative interventions. Clin Microbiol Rev 2000;13:588-601. [PMID: 11023959 DOI: 10.1128/CMR.13.4.588] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 0.8] [Reference Citation Analysis]
16 Schrag SJ, Beall B, Dowell SF. Limiting the spread of resistant pneumococci: biological and epidemiologic evidence for the effectiveness of alternative interventions. Clin Microbiol Rev 2000;13:588-601. [PMID: 11023959 DOI: 10.1128/CMR.13.4.588] [Cited by in Crossref: 48] [Article Influence: 2.2] [Reference Citation Analysis]
17 Hsieh YC, Chang KY, Huang YC, Lin HC, Ho YH, Huang LM, Hsueh PR. Clonal spread of highly beta-lactam-resistant Streptococcus pneumoniae isolates in Taiwan. Antimicrob Agents Chemother 2008;52:2266-9. [PMID: 18413298 DOI: 10.1128/AAC.00046-08] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
18 Pavia AT. Advances in antimicrobial therapy. Semin Pediatr Neurol 1999;6:288-98. [PMID: 10649837 DOI: 10.1016/s1071-9091(99)80027-8] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
19 Crowther-Gibson P, Cohen C, Klugman KP, de Gouveia L, von Gottberg A; Group for Enteric, Respiratory, and Meningeal Disease Surveillance in South Africa (GERMS-SA). Risk factors for multidrug-resistant invasive pneumococcal disease in South Africa, a setting with high HIV prevalence, in the prevaccine era from 2003 to 2008. Antimicrob Agents Chemother 2012;56:5088-95. [PMID: 22802256 DOI: 10.1128/AAC.06463-11] [Cited by in Crossref: 25] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
20 Kühn F, Cottagnoud M, Acosta F, Flatz L, Entenza J, Cottagnoud P. Cefotaxime acts synergistically with levofloxacin in experimental meningitis due to penicillin-resistant pneumococci and prevents selection of levofloxacin-resistant mutants in vitro. Antimicrob Agents Chemother 2003;47:2487-91. [PMID: 12878509 DOI: 10.1128/AAC.47.8.2487-2491.2003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
21 Schrag SJ, McGee L, Whitney CG, Beall B, Craig AS, Choate ME, Jorgensen JH, Facklam RR, Klugman KP; Active Bacterial Core Surveillance Team. Emergence of Streptococcus pneumoniae with very-high-level resistance to penicillin. Antimicrob Agents Chemother 2004;48:3016-23. [PMID: 15273115 DOI: 10.1128/AAC.48.8.3016-3023.2004] [Cited by in Crossref: 70] [Cited by in F6Publishing: 25] [Article Influence: 3.9] [Reference Citation Analysis]
22 Kumar KM, Anitha P, Sivasakthi V, Bag S, Lavanya P, Anbarasu A, Ramaiah S. In silico study on Penicillin derivatives and Cephalosporins for upper respiratory tract bacterial pathogens. 3 Biotech 2014;4:241-51. [PMID: 28324428 DOI: 10.1007/s13205-013-0147-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
23 Dridi B, Lupien A, Bergeron MG, Leprohon P, Ouellette M. Differences in antibiotic-induced oxidative stress responses between laboratory and clinical isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother 2015;59:5420-6. [PMID: 26100702 DOI: 10.1128/AAC.00316-15] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 2.1] [Reference Citation Analysis]
24 Van Beneden CA, Lexau C, Baughman W, Barnes B, Bennett N, Cassidy PM, Pass M, Gelling L, Barrett NL, Zell ER, Whitney CG. Aggregated antibiograms and monitoring of drug-resistant Streptococcus pneumoniae. Emerg Infect Dis 2003;9:1089-95. [PMID: 14519245 DOI: 10.3201/eid0909.020620] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
25 Doern GV, Brueggemann AB, Huynh H, Wingert E. Antimicrobial resistance with Streptococcus pneumoniae in the United States, 1997 98. Emerg Infect Dis 1999;5:757-65. [PMID: 10603208 DOI: 10.3201/eid0506.990603] [Cited by in Crossref: 153] [Cited by in F6Publishing: 133] [Article Influence: 7.0] [Reference Citation Analysis]
26 Zeckel ML, Preston DA, Allen BS. In vitro activities of LY333328 and comparative agents against nosocomial gram-positive pathogens collected in a 1997 global surveillance study. Antimicrob Agents Chemother 2000;44:1370-4. [PMID: 10770782 DOI: 10.1128/AAC.44.5.1370-1374.2000] [Cited by in Crossref: 42] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
27 Cottagnoud P, Pfister M, Cottagnoud M, Acosta F, Täuber MG. Activities of ertapenem, a new long-acting carbapenem, against penicillin-sensitive or -resistant pneumococci in experimental meningitis. Antimicrob Agents Chemother 2003;47:1943-7. [PMID: 12760871 DOI: 10.1128/AAC.47.6.1943-1947.2003] [Cited by in Crossref: 25] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
28 Negara BFSP, Sohn JH, Kim JS, Choi JS. Antifungal and Larvicidal Activities of Phlorotannins from Brown Seaweeds. Mar Drugs 2021;19:223. [PMID: 33923448 DOI: 10.3390/md19040223] [Reference Citation Analysis]
29 Domínguez J, Blanco S, Rodrigo C, Azuara M, Galí N, Mainou A, Esteve A, Castellví A, Prat C, Matas L, Ausina V. Usefulness of urinary antigen detection by an immunochromatographic test for diagnosis of pneumococcal pneumonia in children. J Clin Microbiol 2003;41:2161-3. [PMID: 12734268 DOI: 10.1128/JCM.41.5.2161-2163.2003] [Cited by in Crossref: 76] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
30 Cottagnoud P, Cottagnoud M, Täuber MG. Vancomycin acts synergistically with gentamicin against penicillin-resistant pneumococci by increasing the intracellular penetration of gentamicin. Antimicrob Agents Chemother 2003;47:144-7. [PMID: 12499182 DOI: 10.1128/AAC.47.1.144-147.2003] [Cited by in Crossref: 30] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
31 McGee L, Klugman KP, Wasas A, Capper T, Brink A. Serotype 19f multiresistant pneumococcal clone harboring two erythromycin resistance determinants (erm(B) and mef(A)) in South Africa. Antimicrob Agents Chemother 2001;45:1595-8. [PMID: 11302838 DOI: 10.1128/AAC.45.5.1595-1598.2001] [Cited by in Crossref: 56] [Cited by in F6Publishing: 29] [Article Influence: 2.7] [Reference Citation Analysis]
32 Kim SW, Jin JH, Kang SJ, Jung SI, Kim YS, Kim CK, Lee H, Oh WS, Kim S, Peck KR, Song JH. Therapeutic efficacy of meropenem for treatment of experimental penicillin-resistant pneumococcal meningitis. J Korean Med Sci 2004;19:21-6. [PMID: 14966336 DOI: 10.3346/jkms.2004.19.1.21] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
33 Grupo de trabajo de la Asociación Latinoamericana del Tórax (ALAT). [Update to the Latin American Thoracic Association (ALAT) recommendations on community acquired pneumonia]. Arch Bronconeumol 2004;40:364-74. [PMID: 15274866 DOI: 10.1016/s1579-2129(06)60322-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
34 Amin B, Avaznia M, Noorani R, Mehri S, Hosseinzadeh H. Upregulation of Glutamate Transporter 1 by Clavulanic Acid Administration and Attenuation of Allodynia and Hyperalgesia in Neuropathic Rats. Basic Clin Neurosci 2019;10:345-54. [PMID: 32231771 DOI: 10.32598/bcn.9.10.110] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
35 Chan WT, Balsa D, Espinosa M. One cannot rule them all: Are bacterial toxins-antitoxins druggable? FEMS Microbiol Rev 2015;39:522-40. [PMID: 25796610 DOI: 10.1093/femsre/fuv002] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 7.6] [Reference Citation Analysis]
36 Qureishi A, Lee Y, Belfield K, Birchall JP, Daniel M. Update on otitis media - prevention and treatment. Infect Drug Resist 2014;7:15-24. [PMID: 24453496 DOI: 10.2147/IDR.S39637] [Cited by in Crossref: 25] [Cited by in F6Publishing: 52] [Article Influence: 3.1] [Reference Citation Analysis]
37 Gouveia EL, Reis JN, Flannery B, Cordeiro SM, Lima JB, Pinheiro RM, Salgado K, Mascarenhas AV, Carvalho MG, Beall BW, Reis MG, Ko AI. Clinical outcome of pneumococcal meningitis during the emergence of pencillin-resistant Streptococcus pneumoniae: an observational study. BMC Infect Dis 2011;11:323. [PMID: 22103652 DOI: 10.1186/1471-2334-11-323] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
38 Cottagnoud P, Entenza JM, Cottagnoud M, Que YA, Moreillon P, Taüber MG. Sub-inhibitory concentrations of vancomycin prevent quinolone-resistance in a penicillin-resistant isolate of Streptococcus pneumoniae. BMC Microbiol 2001;1:9. [PMID: 11454238 DOI: 10.1186/1471-2180-1-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 0.2] [Reference Citation Analysis]
39 Doern GV, Heilmann KP, Huynh HK, Rhomberg PR, Coffman SL, Brueggemann AB. Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999--2000, including a comparison of resistance rates since 1994--1995. Antimicrob Agents Chemother 2001;45:1721-9. [PMID: 11353617 DOI: 10.1128/AAC.45.6.1721-1729.2001] [Cited by in Crossref: 409] [Cited by in F6Publishing: 102] [Article Influence: 19.5] [Reference Citation Analysis]
40 Hsueh PR, Teng LJ, Lee LN, Yang PC, Ho SW, Luh KT. Extremely high incidence of macrolide and trimethoprim-sulfamethoxazole resistance among clinical isolates of Streptococcus pneumoniae in Taiwan. J Clin Microbiol 1999;37:897-901. [PMID: 10074498 DOI: 10.1128/JCM.37.4.897-901.1999] [Cited by in Crossref: 55] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
41 Benbachir M, Benredjeb S, Boye CS, Dosso M, Belabbes H, Kamoun A, Kaire O, Elmdaghri N. Two-year surveillance of antibiotic resistance in Streptococcus pneumoniae in four African cities. Antimicrob Agents Chemother 2001;45:627-9. [PMID: 11158769 DOI: 10.1128/AAC.45.2.627-629.2001] [Cited by in Crossref: 33] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
42 Ressner RA, Moore MR, Jorgensen JH. Activity of the Diaminopyrimidine AR-709 against recently collected multidrug-resistant isolates of invasive Streptococcus pneumoniae from North America. Antimicrob Agents Chemother 2008;52:1147-9. [PMID: 18180346 DOI: 10.1128/AAC.01387-07] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
43 Mizrahi A, Marvaud JC, Pilmis B, Nguyen Van JC, Couzigou C, Bruel C, Engrand N, Le Monnier A, Lambert T. Emergence of Ceftriaxone Resistance during a Case of Pneumococcal Meningitis with Fatal Evolution. Antimicrob Agents Chemother 2020;64:e01958-19. [PMID: 31712218 DOI: 10.1128/AAC.01958-19] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
44 Rocha P, Baleeiro C, Tunkel AR. Impact of Antimicrobial Resistance on the Treatment of Invasive Pneumococcal Infections. Curr Infect Dis Rep 2000;2:399-408. [PMID: 11095884 DOI: 10.1007/s11908-000-0066-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
45 Erlendsdottir H, Knudsen JD, Odenholt I, Cars O, Espersen F, Frimodt-Møller N, Fuursted K, Kristinsson KG, Gudmundsson S. Penicillin pharmacodynamics in four experimental pneumococcal infection models. Antimicrob Agents Chemother 2001;45:1078-85. [PMID: 11257018 DOI: 10.1128/AAC.45.4.1078-1085.2001] [Cited by in Crossref: 30] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
46 Cottagnoud P, Cottagnoud M, Acosta F, Flatz L, Kühn F, Stucki A, Entenza J. Meropenem prevents levofloxacin-induced resistance in penicillin-resistant pneumococci and acts synergistically with levofloxacin in experimental meningitis. Eur J Clin Microbiol Infect Dis 2003;22:656-62. [PMID: 14557920 DOI: 10.1007/s10096-003-1016-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]